NCT05000840View on ClinicalTrials.gov

Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA

Active, not recruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

March 31, 2025

Conditions
Diabetes Mellitus, Type 2Cardiovascular Diseases
Interventions
BEHAVIORAL

Enrollment in existing SDRI diabetes education programs

Education will be based on a modification of the existing Ocho Pasos education program provided by SDRI.

Trial Locations (1)

93105

Sansum Diabetes Research Institute, Santa Barbara

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

DexCom, Inc.

INDUSTRY

lead

Sansum Diabetes Research Institute

OTHER